In order to accelerate the innovative development of mRNA technology and drugs, and explore the promotion of a good ecological construction in the biopharmaceutical industry, the mRNA Technology and Drug Innovation Summit Forum (hereinafter referred to as the "Forum") is scheduled to be held from October 25th to October 27th, 2024 at the Crowne Plaza East Lake Optics Valley Hotel in Wuhan.

The forum, with the theme of "strengthening breakthroughs in mRNA independent intellectual property rights and the construction of the entire industry chain, promoting the integration of new technologies and industries", invited numerous industry experts, scholars, and enterprise representatives to give speeches, comprehensively showcasing the cutting-edge progress of mRNA technology and its application in major disease spectra, and fully exchanging the challenges and opportunities faced by mRNA innovative technology and industrial development.

Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") will set up a dedicated booth at the venue, looking forward to academic discussions with you.

Shandong Xinbo has established a comprehensive safety evaluation platform for preventive and therapeutic vaccines, with rich experience in preclinical pharmacological and toxicological research of nucleic acid vaccines.

   Safety evaluation platform for preventive and therapeutic vaccines   
Preclinical research on preventive and therapeutic vaccines can be conducted, including the establishment of overall methodology, detection of specific indicators, pharmacokinetic/toxicokinetic testing, and comprehensive preclinical safety evaluation.

At present, the varieties developed include attenuated vaccine, inactivated vaccine, recombinant vaccine, vector vaccine and nucleic acid vaccine, covering HFMD vaccine, rotavirus vaccine, hepatitis vaccine, human papillomavirus vaccine, rabies vaccine, AIDS vaccine, DPT vaccine, rubella vaccine, influenza vaccine, respiratory syncytial virus vaccine, coronavirus vaccine, herpes zoster vaccine and other vaccines as well as the evaluation of new adjuvants.



Single dose toxicity test (rodent and non rodent)
Repeated administration toxicity test (rodent and non rodent)
■ Safety pharmacology testing
■ Pharmacokinetic/toxicokinetic testing (including methodological establishment and validation)
■ Reproductive toxicity test (Stage I, II, III)
■ Local toxicity test
■ Immunogenicity testing (including methodological establishment and validation)